查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466355

研究抗体市场：按适应症、按操作、按产品、按来源、按技术、按类型、按最终用户 - 2024-2030 年，全球预测

Research Antibodies Market by Indication (Immunology, Infectious Diseases, Neurobiology), Operation (Drug Development, Genomics, Proteomics), Product, Source, Technology, Type, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

研究抗体市场规模预计2023年为62.7亿美元，预计2024年将达到67.9亿美元，2030年将达到110.5亿美元，复合年增长率为8.43%。

研究抗体市场是指围绕科学研究目的抗体的生产、分销和应用的全球产业。抗体是免疫系统用来辨识和平衡细菌和病毒等外来物质的蛋白质。在研究中，抗体可用于多种应用，包括西方印渍术、流式细胞技术、免疫沉淀、萤光和 ELISA。这些抗体的最终用途通常出现在製药和生物技术公司、学术研究机构和受託研究机构中。由于它们用途广泛，市场规模较大，需要开发创新且高度特异性的抗体来满足多样化的研究需求。研究抗体市场的成长受到多种因素的影响，包括基因组学和蛋白​​质组学研究的日益普及、研究抗体的临床试验和核准的增加以及製药和生物技术公司对研发的投资不断增加。然而，研究抗体市场面临着诸如高品质研究抗体的高生产和采购成本、与研究抗体相关的品质问题以及关于在抗体生产中使用动物的法规的增加等挑战。另一方面，个人化医疗和生物标记的普及、开发新药投资和资金筹措的增加以及从传统多株抗体到基因工程抗体的转变将为未来几年的研究抗体市场带来潜力。

主要市场统计
基准年[2023] 62.7亿美元
预测年份 [2024] 67.9亿美元
预测年份 [2030] 110.5亿美元
复合年增长率（%） 8.43%

偏好越来越倾向于免疫学研究抗体，旨在阐明自体免疫疾病

在免疫学中，研究抗体是用于研究免疫系统组成部分的重要工具，包括 T 细胞和 B 细胞等细胞类型、细胞激素等讯号蛋白以及各种免疫途径。对免疫学的需求通常是由了解自体免疫疾病、过敏和免疫力缺乏的需要所驱动的。用于感染疾病研究的抗体主要用于研究人体对病原体的反应以及识别和表征病原体本身。整体而言，对抗新出现的感染疾病和流行病的抗体的需求量很大。有效的抗体开发可以改善诊断、疫苗和治疗方法。在神经生物学领域，研究抗体促进了脑功能、神经退化性疾病和精神疾病的研究。针对神经元标记物、神经传导物质和受体的抗体需求量很大，尤其是针对阿兹海默症和帕金森氏症等疾病。抗体对于癌症研究至关重要，包括肿瘤学肿瘤标记识别、癌细胞信号传导和免疫肿瘤学。不断寻求更有效的癌症诊断和治疗方法推动了需求。干细胞研究抗体用于识别和分离干细胞、区分干细胞类型并追踪分化途径。干细胞研究是一个快速发展的领域，需求集中在再生医学和发育生物学研究。比较每个领域的指标表明，根据疾病领域的复杂性和每个领域的进展速度，对研究抗体的需求存在很大差异。由于对抗自体免疫疾病和癌症的持续挑战，免疫学和肿瘤学是一直需求量大的领域。相反，为了应对新的健康危机，感染疾病的需求通常会激增。神经生物学和干细胞研究处于科学发现的前沿，需要高度专业化的抗体来解决独特的研究问题。神经生物学中大脑和中枢神经系统的复杂性以及干细胞生物学的动态性质需要抗体製造商不断创新。

最终用户：扩大研究抗体在製药和生技公司的使用

学术和研究机构需要抗体用于多种目的，包括基础研究、疾病研究和教育目的。由于这些机构的研究主题广泛，他们更喜欢价格实惠且具有多种特异性和用途的抗体。该细分市场专注于教育折扣和机构交易，并且经常寻求大量购买选择。在製药和生物技术领域，药物发现和药物开发过程需要高品质、高重复性和经过验证的抗体。他们的需求主要集中在治疗性抗体开发、生物标记发现和体外诊断。因此，在高通量和临床环境中具有保证性能的高级、专用抗体是首选。将学术和研究机构与製药和生物技术公司进行比较时，研究抗体需求存在一些重要差异。在学术和研究机构，研究主题往往更加多样化和多样化，因此抗体需要具有多功能性和成本效益。相较之下，製药和生技公司优先考虑抗体的重现性和可靠性，特别是当它们在治疗研究和诊断方面面临严格的监管要求时。

区域洞察

在美国，对高品质研究抗体的需求强劲，主要是由于大型製药公司的存在、生物技术和生命科学领域的集中研发工作以及政府和私营部门的大量投资。着名的资助机构美国国立卫生研究院 (NIH) 继续采取倡议支持生物医学研究，这对抗体市场产生了积极影响。加拿大市场的特点是生物技术产业不断发展，政府对医学研究的资助不断增加。南美洲的研究抗体市场正在发展，由于医疗保健系统的改善、政府和私人研究支持的增加以及非传染性疾病的增加，巴西和阿根廷等国家推动了该地区的需求。欧盟国家拥有完善的製药和生物技术产业以及强大的学术研究活动，因此对研究型抗体的需求很高。然而，严格的监管政策可能会限制市场成长。注重研究活动的创新和永续性仍然是欧洲国家（包括英国、英国和法国）的中心趋势。随着医疗保健和研究基础设施投资的增加，中东研究抗体市场正在不断发展。非洲研究抗体市场相对开拓，具有巨大的成长潜力。由于新兴经济体、医疗保健资金的增加和研究领域的扩大，亚太地区的市场正在快速成长。中国的抗体市场正在快速成长，生物製药研发投入庞大，学名药产业蓬勃发展。日本拥有成熟的製药业和创新传统，使其成为研究抗体的重要市场。日本以其高标准的研究而闻名，客户需要具有高特异性和重现性的抗体。印度是一个快速发展的市场，生物相似药研究激增，生物技术产业蓬勃发展。

FPNV定位矩阵

FPNV定位矩阵对于评估研究抗体市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对研究抗体市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估及资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行综合评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.研究抗体市场的市场规模和预测是多少？

2.在研究抗体市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3. 研究抗体市场的技术趋势和法规结构是什么？

4.研究抗体市场主要厂商的市场占有率为何？

5.进入研究型抗体市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 基因组学和蛋白​​质组学研究日益普及
      • 研究抗体的临床试验和核准不断增加
    • 抑制因素
      • 抗体开发过程耗时且成本高昂
    • 机会
      • 个人化医疗和生物标记的普及
      • 加大开发新药投入与资金投入
    • 任务
      • 与研究抗体相关的品质问题
  • 市场区隔分析
    • 适应症：越来越倾向免疫学研究抗体来了解自体免疫疾病
    • 最终用户：扩大研究抗体在製药和生技公司的使用
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章 研究抗体市场：依迹象分类

  • 免疫学
  • 感染疾病
  • 神经生物学
  • 肿瘤学
  • 干细胞

第七章 研究抗体市场：依营运划分

  • 药物开发
  • 基因组学
  • 蛋白质体学

第八章研究抗体市场：副产品

  • 单株抗体
  • 多株抗体

第 9 章 研究抗体市场：依来源分类

  • 山羊
  • 老鼠
  • 兔子

第10章研究抗体市场：依技术分类

  • 酵素免疫分析法
  • 流式细胞技术
  • 萤光
  • 免疫组织化学
  • 免疫沉淀分析法
  • 蛋白质印迹法

第十一章研究抗体市场：按类型

  • 一抗
  • 二抗

第十二章 研究抗体市场：依最终用户

  • 学术研究所
  • 製药和生物技术公司

第十三章美洲抗体市场研究

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十四章亚太研究抗体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十五章欧洲、中东和非洲研究抗体市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十六章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 丹纳赫完成收购 Abcam
    • 艾伯维 (AbbVie) 和 Big Hat Biosciences 宣布开展研究合作，利用人工智慧和机器学习发现下一代治疗抗体
    • AbCellera 和加拿大投资超过 5 亿美元加强抗体生产和研究

第十七章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-4312A385A328

[182 Pages Report] The Research Antibodies Market size was estimated at USD 6.27 billion in 2023 and expected to reach USD 6.79 billion in 2024, at a CAGR 8.43% to reach USD 11.05 billion by 2030.

The market for research antibodies refers to the global industry that revolves around the production, distribution, and application of antibodies for scientific research purposes. Antibodies are proteins utilized by the immune system to recognize and balance foreign substances, such as bacteria and viruses. In the research context, antibodies can be used in multiple applications, such as western blotting, flow cytometry, immunoprecipitation, immunofluorescence, and ELISA. The end-use for these antibodies is typically found in pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations. The broad application base provides a wide market scope, with demand driving the development of innovative and high-specific antibodies for diverse research needs. The growth of the research antibodies market is influenced by several factors, including the rising popularity of genomics and proteomics research, increasing clinical trials and approvals of research antibodies, and heightened investment in R&D by pharmaceutical and biotech firms. However, the research antibodies market faces certain challenges, such as the high cost of production and procurement of high-quality research antibodies, quality concerns associated with research antibodies, and tightening regulations regarding the use of animals in antibody production. On the other hand, the proliferation of personalized medicine and biomarkers, increasing investment and funding for novel drug development, and the shift from traditional polyclonal antibodies to recombinant antibodies present potential opportunities for the research antibodies market in the coming years.

KEY MARKET STATISTICS
Base Year [2023] USD 6.27 billion
Estimated Year [2024] USD 6.79 billion
Forecast Year [2030] USD 11.05 billion
CAGR (%) 8.43%

Indication: Increasing preference for research antibodies in immunology to understand autoimmune diseases

In immunology, research antibodies are essential tools used to study the components of the immune system, including cell types such as T cells and B cells, signaling proteins, including cytokines, and various immunological pathways. Demand in immunology is frequently driven by the need to understand autoimmune diseases, allergies, and immune deficiencies. Research antibodies for infectious diseases are predominantly utilized to investigate the body's responses to pathogens and to identify and characterize the pathogens themselves. Demand is typically high for antibodies that can help combat emerging infectious diseases and pandemics. Effective antibody development can lead to improved diagnostics, vaccines, and therapies. In the neurobiology segment, research antibodies facilitate the study of brain function, neurodegenerative diseases, and psychiatric disorders. Antibodies against neuronal markers, neurotransmitters, and receptors are in high demand, particularly for illnesses such as Alzheimer's and Parkinson's. Oncology research antibodies are critical for cancer research, including tumor marker identification, cancer cell signaling, and immuno-oncology. Demand is driven by the ongoing search for more effective cancer diagnostics and treatments. Research antibodies directed at stem cells are used to identify and isolate stem cells, differentiate between stem cell types, and track differentiation pathways. Stem cell research is a rapidly progressing field, with demand often focusing on regenerative medicine and developmental biology studies. When comparing indicators across the spectrum, it's apparent that the need for research antibodies varies significantly depending on the complexity of the disease area and the rate of advancements in each field. Immunology and oncology are perennially high-demand sectors due to the ongoing challenges in combating autoimmune diseases and cancer. Conversely, infectious diseases see demand spikes typically in response to emerging health crises. Neurobiology and stem cell research can be categorized as frontiers of scientific discovery, requiring highly specialized antibodies to address unique research challenges. The complexity of the brain and central nervous system in neurobiology and the dynamic nature of stem cell biology necessitates constant innovation from antibody manufacturers.

End User: Expanding usage of research antibodies among pharmaceutical & biotechnology companies

Academic and research institutes predominantly require antibodies for various applications such as basic research, disease studies, and educational purposes. These institutions favor antibodies that are both affordable and offer a wide variety of specificities and applications, given the breadth of research topics pursued. This segment often seeks bulk purchasing options, emphasizing educational discounts and institutional deals. The pharmaceutical and biotechnology sector demands high-quality, reproducible, and validated antibodies for drug discovery and development processes. Their needs mainly focus on therapeutic antibody development, biomarker discovery, and in vitro diagnostics. Thus, their preference leans toward premium and specialized antibodies that guarantee performance in high-throughput and clinical settings. When comparing academic and research institutes to pharmaceutical and biotechnology companies, several key differences in research antibody requirements arise. Academic and research institutes often have more diverse and variable research interests, thus seeking versatility and cost-effectiveness in their antibodies. In contrast, pharmaceutical and biotechnology companies prioritize the reproducibility and reliability of antibodies, given the stringent regulatory requirements they face, particularly for therapeutic research and diagnostics.

Regional Insights

In the United States, there is a robust demand for high-quality research antibodies, primarily due to the presence of major pharmaceutical companies, a strong focus on R&D in biotechnology and life sciences, and significant government and private investment. The National Institutes of Health (NIH), a prominent funding body, has a continuing initiative to support biomedical research, which positively impacts the antibody market. Canada's market is characterized by a growing biotechnology industry and increased government funding in medical research. In South America, the research antibodies market is evolving, with countries such as Brazil and Argentina spearheading regional demand due to improving healthcare systems, increased governmental and private support for research, and a rise in non-communicable diseases. EU countries exhibit a strong demand for research antibodies due to well-established pharmaceutical and biotech industries, alongside extensive academic research activities. However, stringent regulatory policies may impose limitations on the market's growth. Focus on innovation and sustainability within research practices remains a central trend in European countries, including Germany, the UK, and France. The research antibody market in the Middle East is evolving with increasing investment in healthcare and research infrastructure. Africa's research antibody market is relatively untapped, with significant potential for growth. The APAC region exhibits rapid market growth due to emerging economies, increased healthcare funding, and expanding research sectors. China's antibody market is rapidly growing, with significant investments in biopharmaceutical R&D and a flourishing generics industry. Japan has an established pharmaceutical sector with a tradition of innovation, making it a significant market for research antibodies. Japan is known for its high standards in research practices, leading customers to demand antibodies with high specificity and reproducibility. India presents a rapidly evolving market with a surge in biosimilar research and a burgeoning biotech industry.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Research Antibodies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Research Antibodies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Research Antibodies Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Absolute Antibody Ltd., Agilent Technologies, Inc., AvantGen, Inc., Becton, Dickinson and Company, Bio X Cell, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cell Signaling Technology, Inc., Danaher Corporation, Enzo Life Sciences, Inc., F. Hoffmann-La Roche AG, GenScript Corporation, Jackson ImmunoResearch Inc., Merck KGaA, PerkinElmer, Inc., PROGEN Biotechnik GmbH, Proteintech Group, Inc., QIAGEN N.V., Santa Cruz Biotechnology Inc., Synaptic Systems GmbH, Sysmex Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Research Antibodies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Immunology
    • Infectious Diseases
    • Neurobiology
    • Oncology
    • Stem Cells
  • Operation
    • Drug Development
    • Genomics
    • Proteomics
  • Product
    • Monoclonal Antibodies
    • Polyclonal Antibodies
  • Source
    • Goat
    • Mouse
    • Rabbit
  • Technology
    • Enzyme-Linked Immunosorbent Assay
    • Flow Cytometry
    • Immunofluorescence
    • Immunohistochemistry
    • Immunoprecipitation
    • Western Blotting
  • Type
    • Primary Antibodies
    • Secondary Antibodies
  • End User
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Research Antibodies Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Research Antibodies Market?

3. What are the technology trends and regulatory frameworks in the Research Antibodies Market?

4. What is the market share of the leading vendors in the Research Antibodies Market?

5. Which modes and strategic moves are suitable for entering the Research Antibodies Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Popularity of Genomics and Proteomics Research
      • 5.1.1.2. Increasing Clinical Trials and Approvals of Research Antibodies
    • 5.1.2. Restraints
      • 5.1.2.1. Time and Cost Consuming Antibody Development Processes
    • 5.1.3. Opportunities
      • 5.1.3.1. Proliferation of Personalized Medicine and Biomarkers
      • 5.1.3.2. Increasing Investment and Funding for Novel Drug Development
    • 5.1.4. Challenges
      • 5.1.4.1. Quality Concerns Associated with Research Antibodies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: Increasing preference for research antibodies in immunology to understand autoimmune diseases
    • 5.2.2. End User: Expanding usage of research antibodies among pharmaceutical & biotechnology companies
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Research Antibodies Market, by Indication

  • 6.1. Introduction
  • 6.2. Immunology
  • 6.3. Infectious Diseases
  • 6.4. Neurobiology
  • 6.5. Oncology
  • 6.6. Stem Cells

7. Research Antibodies Market, by Operation

  • 7.1. Introduction
  • 7.2. Drug Development
  • 7.3. Genomics
  • 7.4. Proteomics

8. Research Antibodies Market, by Product

  • 8.1. Introduction
  • 8.2. Monoclonal Antibodies
  • 8.3. Polyclonal Antibodies

9. Research Antibodies Market, by Source

  • 9.1. Introduction
  • 9.2. Goat
  • 9.3. Mouse
  • 9.4. Rabbit

10. Research Antibodies Market, by Technology

  • 10.1. Introduction
  • 10.2. Enzyme-Linked Immunosorbent Assay
  • 10.3. Flow Cytometry
  • 10.4. Immunofluorescence
  • 10.5. Immunohistochemistry
  • 10.6. Immunoprecipitation
  • 10.7. Western Blotting

11. Research Antibodies Market, by Type

  • 11.1. Introduction
  • 11.2. Primary Antibodies
  • 11.3. Secondary Antibodies

12. Research Antibodies Market, by End User

  • 12.1. Introduction
  • 12.2. Academic & Research Institutes
  • 12.3. Pharmaceutical & Biotechnology Companies

13. Americas Research Antibodies Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Research Antibodies Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Research Antibodies Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
    • 16.3.1. Danaher Completes Acquisition of Abcam
    • 16.3.2. AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
    • 16.3.3. AbCellera and Canada to invest $500M+ to boost antibody manufacturing and research

17. Competitive Portfolio

  • 17.1. Key Company Profiles
  • 17.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. RESEARCH ANTIBODIES MARKET RESEARCH PROCESS
  • FIGURE 2. RESEARCH ANTIBODIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. RESEARCH ANTIBODIES MARKET DYNAMICS
  • FIGURE 7. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 18. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 20. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 24. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 26. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 28. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 29. RESEARCH ANTIBODIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 30. RESEARCH ANTIBODIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RESEARCH ANTIBODIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GENOMICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GENOMICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PROTEOMICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GOAT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY GOAT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MOUSE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY MOUSE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY RABBIT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY RABBIT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOPRECIPITATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY IMMUNOPRECIPITATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL RESEARCH ANTIBODIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 93. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 101. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 104. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 105. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 106. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 110. BRAZIL RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 113. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 114. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 115. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 116. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 117. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 118. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. CANADA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 126. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 127. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 128. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 129. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 132. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 133. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 134. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 135. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 138. MEXICO RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 139. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 140. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 143. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 147. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 148. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 149. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES RESEARCH ANTIBODIES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 174. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 175. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 176. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 177. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 178. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 184. AUSTRALIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 185. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 186. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 187. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 188. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 189. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 190. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 191. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 192. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 193. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 198. CHINA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 199. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 200. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 201. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 202. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 203. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 206. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 207. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 208. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 209. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 212. INDIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 213. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 216. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 217. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 220. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 221. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 222. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 223. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 226. INDONESIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 227. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 228. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 229. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 230. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 231. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 232. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 233. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 234. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 235. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 240. JAPAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 241. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 242. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 243. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 244. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 245. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 248. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 249. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 250. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 251. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 254. MALAYSIA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 255. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 256. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 257. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 258. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 259. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 262. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 264. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. PHILIPPINES RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 270. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 271. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 272. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 273. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 276. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 277. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 282. SINGAPORE RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 283. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 284. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 285. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 286. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 287. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 288. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 289. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 290. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 292. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 296. SOUTH KOREA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 297. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 298. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 299. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 300. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 301. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 304. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 305. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 306. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 307. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 310. TAIWAN RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 311. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 312. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 313. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 314. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 315. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 318. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 319. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 320. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 321. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 324. THAILAND RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 325. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 326. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 327. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 328. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 329. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 330. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 331. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 332. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 333. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 334. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 335. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 338. VIETNAM RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 339. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 340. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 341. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2018-2023 (USD MILLION)
  • TABLE 342. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY OPERATION, 2024-2030 (USD MILLION)
  • TABLE 343. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 344. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 345. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 346. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 347. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 348. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 349. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 350. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 351. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 352. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 353. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 354. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 355. DENMARK RESEARCH ANTIBODIES MARKET SIZE, BY INDICATION, 2018-2023 (USD